HER3 inhibitors (University of Queensland)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHER3 inhibitors (University of Queensland)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 antagonists
TargetsReceptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniquest Pty LtdThe University Of Queensland
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancer

Other Information

ATC CodeN/A
Related LinksN/A